Fitoussi G, Nègre-Salvayre A, Pieraggi M T, Salvayre R
Department of Biochemistry, Faculty of Medicine in Rangueil, INSERM (CJF-9206), Toulouse, France.
Biochem J. 1994 Jul 1;301 ( Pt 1)(Pt 1):267-73. doi: 10.1042/bj3010267.
Wolman disease in an inherited metabolic disease, characterized by a severe deficiency of the acid lipase and a massive lysosomal storage of triacylglycerols and cholesteryl esters, associated with hepatosplenomegaly, adrenal calcification and nearly always fatal in the first year of life. Cultured human lymphoblastoid cells and human adrenal cells are able to promote the formation of mildly oxidized low-density lipoproteins (LDL), which in turn exhibit a non-negligible cytotoxic effect on these cells. In contrast, fibroblasts induce only very low levels of LDL oxidation. Comparative experiments have shown that the cytotoxic effect of oxidized LDL was higher to Wolman-disease cells than to controls. The oxidative ability of Wolman cells was similar to that of normal ones. The over-cytotoxicity of mildly oxidized LDL to Wolman cells resulted from the higher uptake of mildly oxidized LDL through the LDL-receptor pathway, which is only poorly down-regulated in Wolman cells subsequently to the block of the lysosomal degradation of LDL-cholesteryl esters. In cultured adrenal cells, oxidized LDL induced a sustained rise in intracellular [Ca2+] which is directly involved in the cellular damage and cell death induced by oxidized LDL [Nègre-Salvayre and Salvayre (1992) Biochim. Biophys. Acta 1123, 207-215]. This Ca2+ peak is followed by a dramatic deposition of calcium in damaged or/and dead cultured adrenal cells, quite similar to that observed in Wolman-disease adrenal cortex. The cell-induced LDL oxidation and the subsequent cytotoxic effect can be prevented, at least in part, by antioxidants such as alpha-tocopherol and nordihydroguaiaretic acid. These findings support the hypothesis that the Wolman-disease adrenal damage (necrosis and calcification) could result from the association of the following events: mild oxidation of LDL by adrenal cells, over-uptake of mildly oxidized LDL by Wolman cells (resulting from the block of the lysosomal degradation of cholesteryl esters in Wolman cells), and cytotoxicity related to the amount of mildly oxidized LDL internalized by cells. The reported data also suggest that LDL oxidation induced by adrenal cells and their subsequent cytotoxicity can be prevented (in part) by antioxidants, and the potential therapeutic use of antioxidants in Wolman disease is discussed.
沃尔曼病是一种遗传性代谢疾病,其特征为酸性脂肪酶严重缺乏,三酰甘油和胆固醇酯在溶酶体大量蓄积,伴有肝脾肿大、肾上腺钙化,且在生命的第一年几乎总是致命的。培养的人淋巴母细胞和人肾上腺细胞能够促进轻度氧化的低密度脂蛋白(LDL)的形成,而这种脂蛋白反过来又对这些细胞表现出不可忽视的细胞毒性作用。相比之下,成纤维细胞仅诱导极低水平的LDL氧化。比较实验表明,氧化LDL对沃尔曼病细胞的细胞毒性作用比对对照细胞更高。沃尔曼病细胞的氧化能力与正常细胞相似。轻度氧化的LDL对沃尔曼病细胞的过度细胞毒性是由于通过LDL受体途径对轻度氧化的LDL摄取增加所致,在沃尔曼病细胞中,LDL - 胆固醇酯的溶酶体降解受阻后,该途径的下调程度很低。在培养的肾上腺细胞中,氧化LDL诱导细胞内[Ca2+]持续升高,这直接参与了氧化LDL诱导的细胞损伤和细胞死亡 [内格雷 - 萨尔维耶尔和萨尔维耶尔(1992年)《生物化学与生物物理学学报》1123,207 - 215]。这个Ca2+峰值之后,受损或/和死亡的培养肾上腺细胞中会有大量钙沉积,这与在沃尔曼病肾上腺皮质中观察到的情况非常相似。细胞诱导的LDL氧化及其随后的细胞毒性作用至少可以部分地被抗氧化剂如α - 生育酚和去甲二氢愈创木酸所阻止。这些发现支持了这样一种假说,即沃尔曼病肾上腺损伤(坏死和钙化)可能是由以下事件共同作用导致的:肾上腺细胞对LDL的轻度氧化、沃尔曼病细胞对轻度氧化的LDL过度摄取(这是由于沃尔曼病细胞中胆固醇酯的溶酶体降解受阻所致)以及与细胞内化的轻度氧化LDL量相关的细胞毒性。所报道的数据还表明,肾上腺细胞诱导LDL氧化及其随后的细胞毒性作用可以(部分)被抗氧化剂阻止,并且讨论了抗氧化剂在沃尔曼病中的潜在治疗用途。